Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2025-12-31 @ 8:57 AM
Study NCT ID:
NCT05473195
Status:
COMPLETED
Last Update Posted:
2025-08-21
First Post:
2022-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
Sponsor:
TASK Applied Science
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-12
First Submit QC Date:
None
Study First Post Date:
2022-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-15
Last Update Post Date:
2025-08-21
Last Update Post Date Type:
ACTUAL